Box Hill Hospital is a teaching hospital in Melbourne. It is one of the seven hospitals that are governed within the Eastern Health network which provides health care services across the Eastern metropolitan area of Victoria.

There are 621 beds in Eastern Clinical Research Unit.

During the past decade, Eastern Clinical Research Unit conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastern Clinical Research Unit" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastern Clinical Research Unit" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Baker Heart and Diabetes Institute" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Eastern Clinical Research Unit" are "Alzheimer's Disease" (2 trials), "Asthma" (2 trials), "Atopic Dermatitis" (1 trials), "Diabetes Mellitus Type 2" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Eastern Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "Eastern Clinical Research Unit" are "Drug" (16 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (3 trials), "Tirzepatide" (2 trials), "APD334" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eastern Clinical Research Unit" are 18 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Eastern Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Eastern Clinical Research Unit, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eastern Clinical Research Unit, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".